These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 26690113)
21. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography. Dollé F J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and radiopharmacological characterisation of a fluorine-18-labelled azadipeptide nitrile as a potential PET tracer for in vivo imaging of cysteine cathepsins. Löser R; Bergmann R; Frizler M; Mosch B; Dombrowski L; Kuchar M; Steinbach J; Gütschow M; Pietzsch J ChemMedChem; 2013 Aug; 8(8):1330-44. PubMed ID: 23785011 [TBL] [Abstract][Full Text] [Related]
23. PET Imaging of Receptor Tyrosine Kinases in Cancer. Wei W; Ni D; Ehlerding EB; Luo QY; Cai W Mol Cancer Ther; 2018 Aug; 17(8):1625-1636. PubMed ID: 30068751 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of a [(18)F]-labeled ceritinib analogue for positron emission tomography of anaplastic lymphoma kinase, a receptor tyrosine kinase, in lung cancer. Perera S; Piwnica-Worms D; Alauddin MM J Labelled Comp Radiopharm; 2016 Mar; 59(3):103-8. PubMed ID: 26853088 [TBL] [Abstract][Full Text] [Related]
25. Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PET. Collier TL; Maresca KP; Normandin MD; Richardson P; McCarthy TJ; Liang SH; Waterhouse RN; Vasdev N Mol Imaging; 2017; 16():1536012117736669. PubMed ID: 29067878 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitor. Kniess T; Bergmann R; Kuchar M; Steinbach J; Wuest F Bioorg Med Chem; 2009 Nov; 17(22):7732-42. PubMed ID: 19822433 [TBL] [Abstract][Full Text] [Related]
27. Nuclear imaging probes: from bench to bedside. Wester HJ Clin Cancer Res; 2007 Jun; 13(12):3470-81. PubMed ID: 17575209 [TBL] [Abstract][Full Text] [Related]
28. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2. Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045 [TBL] [Abstract][Full Text] [Related]
29. Predictive efficacy of (11)C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients. Dai D; Li XF; Wang J; Liu JJ; Zhu YJ; Zhang Y; Wang Q; Xu WG Int J Cancer; 2016 Feb; 138(4):1003-12. PubMed ID: 26334931 [TBL] [Abstract][Full Text] [Related]
30. PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy. Sharma P; Kumar R; Alavi A PET Clin; 2015 Oct; 10(4):495-505. PubMed ID: 26384596 [TBL] [Abstract][Full Text] [Related]
31. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors. Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021 [TBL] [Abstract][Full Text] [Related]
32. Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose. Giorgetti A; Volterrani D; Mariani G Radiol Med; 2002 Apr; 103(4):293-318. PubMed ID: 12107381 [TBL] [Abstract][Full Text] [Related]
33. The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET). Banister SD; Manoli M; Kassiou M J Labelled Comp Radiopharm; 2013; 56(3-4):215-24. PubMed ID: 24285328 [TBL] [Abstract][Full Text] [Related]
34. The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3). Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH Bioorg Med Chem Lett; 2011 Jan; 21(1):245-9. PubMed ID: 21115250 [TBL] [Abstract][Full Text] [Related]
35. 5-(4-((4-[(18)F]Fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine: a selective dual inhibitor for potential PET imaging of Trk/CSF-1R. Bernard-Gauthier V; Schirrmacher R Bioorg Med Chem Lett; 2014 Oct; 24(20):4784-90. PubMed ID: 25257201 [TBL] [Abstract][Full Text] [Related]
36. Immuno-PET: a navigator in monoclonal antibody development and applications. van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor. Fang Y; Wang D; Xu X; Liu J; Wu A; Li X; Xue Q; Wang H; Wang H; Zhang H Eur J Med Chem; 2017 Feb; 127():493-508. PubMed ID: 28109944 [TBL] [Abstract][Full Text] [Related]
38. Radiosynthesis and biological evaluation of Huang S; Han Y; Chen M; Hu K; Qi Y; Sun P; Wang M; Wu H; Li G; Wang Q; Du Z; Zhang K; Zhao S; Zheng X Bioorg Med Chem Lett; 2018 Apr; 28(6):1143-1148. PubMed ID: 29486966 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of (Z)-2-((1H-indazol-3-yl)methylene)-6-[¹¹C]methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one as a new potential PET probe for imaging of the enzyme PIM1. Gao M; Wang M; Miller KD; Zheng QH Bioorg Med Chem Lett; 2013 Aug; 23(15):4342-6. PubMed ID: 23791570 [TBL] [Abstract][Full Text] [Related]
40. Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancer. Wagner S; Kopka K Recent Results Cancer Res; 2013; 187():107-32. PubMed ID: 23179879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]